![](/img/cover-not-exists.png)
PRS28 ADD-ON OMALIZUMAB IN PERSISTENT DIFFICULT-TO-TREAT ASTHMA: A 12-MONTH STUDY ON CLINICAL, ECONOMIC OUTCOMES AND RELATED COST/UTILITY
RW Dal Negro, L Pradelli, C Micheletto, S Tognella, S IannazzoVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74490-9
File:
PDF, 92 KB
english, 2009